510(k) Report

510(k) · Cleared

Cleared

MagVenture TMS Therapy System

K251119510(k) TraditionalCleared Aug 8, 2025119-day reviewClass II21 CFR 882.5805

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tonica Elektronik A/S · OBP Transcranial Magnetic Stimulator

Cleared on Aug 8, 2025 as substantially equivalent to K230029 (Neuronetics, 2023) after a 119-day review. Its family tree reaches back 11 generations to 2008. 3 later devices descend from it.

Decided
Aug 8, 2025
Review
119 days
Class
Class II
Product code
OBP
Recalls
None
Predicates
1

Its longest line of descent runs back 11 generations to DEN070003 (2008). 24 ancestors in all. 3 later devices descend from it, 3 citing it directly.

  1. Root · 11 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 7 generations between
  3. 3 generations backK193006 MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS…Tonica Elektronik A/S · 2020
  4. 2 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
  5. 1 generation backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
  6. This deviceK251119 MagVenture TMS Therapy SystemTonica Elektronik A/S · 2025
  7. Descendant · cites it directly · 0 of its ownK260691 BTL-699BTL Industries, Inc. · 2026
  8. Descendant · cites it directly · 0 of its ownK260402 MeRT SystemWave Neuroscience · 2026
  9. Descendant · cites it directly · 0 of its ownK260189 MagVenture Accelerated TMS (aTMS) Therapy SystemTonica Elektronik A/S · 2026
Show all 11 generations
  1. Root · 11 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 10 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 9 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
  4. 8 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
  5. 7 generations backK143531 Rapid Therapy SystemMagstim Company Limited · 2015 · Recalled
  6. 6 generations backK160309 Neurosoft TMSTeleemg, LLC · 2016
  7. 5 generations backK171967 MagVita TMS Therapy SystemTonica Elektronik A/S · 2017
  8. 4 generations backK173620 Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S · 2018
  9. 3 generations backK193006 MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS…Tonica Elektronik A/S · 2020
  10. 2 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
  11. 1 generation backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
  12. This deviceK251119 MagVenture TMS Therapy SystemTonica Elektronik A/S · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K260691BTL-699BTL Industries, Inc. · 2026 · cites it directly0descendants
  • K260402MeRT SystemWave Neuroscience · 2026 · cites it directly0descendants
  • K260189MagVenture Accelerated TMS (aTMS) Therapy SystemTonica Elektronik A/S · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11DEN070003Neurostar TMS SystemNeuronetics2008—
−10K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−9K130233Neurostar TMS Therapy SystemNeuronetics2013—
−8K133408Neurostar TMS Therapy SystemNeuronetics2014—
−7K143531Rapid Therapy SystemMagstim Company Limited20153
−6K160309Neurosoft TMSTeleemg, LLC2016—
−5K171967MagVita TMS Therapy SystemTonica Elektronik A/S2017—
−4K173620Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S2018—
−3K193006MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemTonica Elektronik A/S2020—
−2K212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced…Neuronetics, Inc.2022—
−1K230029NeuroStar Advanced Therapy System (Version 3.7)Neuronetics2023—
0 (this device)K251119MagVenture TMS Therapy SystemTonica Elektronik A/S2025—
+1K260691BTL-699BTL Industries, Inc.2026—
+1K260402MeRT SystemWave Neuroscience2026—
+1K260189MagVenture Accelerated TMS (aTMS) Therapy SystemTonica Elektronik A/S2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
201620
201730
201820
201910
202010
202110
202210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202630
FIG. 1 — Lineage of K251119, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBP device

  1. #1 K220127 NeuroStar TMS Therapy System, NeuroStar…score 20.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K230029NeuroStar Advanced Therapy System (Version 3.7)
Summary page 5
…III. PREDICATE DEVICE Predicate Manufacturer: Neuronetics Predicate Trade Name: NeuroStar Advanced Therapy System Predicate 510(k): K230029 Predicate Regulation: 21 CFR 882.5805, 21 CFR 882.5802 Predicate Product Code: OBP, QCI…
Neuronetics2023—

Also cleared against K230029: 3 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260691BTL-699BTL Industries, Inc.20260
K260402MeRT SystemWave Neuroscience20260
K260189MagVenture Accelerated TMS (aTMS) Therapy SystemTonica Elektronik A/S20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 5 companies; a new generation was cleared every 1.1 years on median.
  • 2 of the 24 ancestors have a recall of any class.
  • Of its descendants, K260691 (BTL Industries, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K230029.

How does its category compare?

All OBP devices

OBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · OBP

12in 2025

2008: 22013: 22014: 12015: 22016: 32017: 82018: 42019: 32020: 12021: 52022: 62023: 72024: 52025: 122026 (partial year): 8
2007high 12 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBP

125in 2025

2016: 101 days median2017: 73 days median2018: 144 days median2019: 156 days median2021: 132 days median2022: 168 days median2023: 119 days median2024: 266 days median2025: 125 days median2026 (partial year): 176 days median
2007high 266 (2024) · low 73 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBP

1in 2018

2009: 12018: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBP

81in 2025

2009: 32011: 52012: 32013: 12015: 32016: 62017: 32018: 62019: 122020: 122021: 152022: 592023: 432024: 502025: 81
2007high 81 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—13
20100—00
20110—05
20120—03
20132—01
20141—00
20152—03
2016310106
201787303
2018414416
20193156012
20201—012
20215132015
20226168059
20237119043
20245266050
202512125081
202681761—

What is it indicated for?

MagVenture TMS Therapy is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.

The MagVenture TMS Therapy system is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251119: MagVenture TMS Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251119

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026